Bumetanide Injection
Product Images NDC 72205-102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 72205-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bumetanide-10ml-crtn-label (Bumetanide 10ml Crtn Label)

Bumetanide-10ml-crtn-label (Bumetanide 10ml Crtn Label)
Package label for Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vials. The label states the injection is for intravenous or intramuscular use, distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions and manufacturer information from MSN Laboratories Private Limited, India. The packaging is designed for 10 vials of 10 mL each.*
FDA Label Image

Bumetanide-10ml-vial-label (Bumetanide 10ml Vial Label)

Bumetanide-10ml-vial-label (Bumetanide 10ml Vial Label)
Label for Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vial. Injection is indicated for intravenous or intramuscular use and contains benzyl alcohol as a preservative. Distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ, and manufactured by MSN Laboratories Private Limited, India. Includes storage instructions and barcode.*
FDA Label Image

Bumetanide-4ml-crtn-label (Bumetanide 4ml Crtn Label)

Bumetanide-4ml-crtn-label (Bumetanide 4ml Crtn Label)
Box packaging label for Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) single-dose vials by Novadoz Pharmaceuticals LLC. The label states the product is for intravenous or intramuscular use and contains 10 vials of 4 mL each. Manufacturer information and storage instructions are included on the label.*
FDA Label Image

Bumetanide-4ml-vial-label (Bumetanide 4ml Vial Label)

Bumetanide-4ml-vial-label (Bumetanide 4ml Vial Label)
Bumetanide Injection USP 1 mg/4 mL (0.25 mg/mL) single-dose vial label for intravenous or intramuscular use. Contains benzyl alcohol preservative. Distributed by Novadoz Pharmaceuticals LLC, labeling includes storage instructions (20° to 25°C), usage directions, and manufacturing details from MSN Laboratories, India, with a barcode and lot number.*
FDA Label Image

Structure (Bumetanide Structure)

Structure (Bumetanide Structure)
Chemical structure of Bumetanide, showing its molecular components including sulfonamide, phenyl, and carboxylic acid groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.